HPV Vaccination
20
5
8
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
10.0%
2 terminated out of 20 trials
71.4%
-15.2% vs benchmark
15%
3 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (20)
Parents' HPV Stories
Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors
OPERATION WIPE OUT: Multi-Channel Communication Campaign to Promote HPV Vaccination in Chambers County, Alabama
Trial in HPV Prevention for the U.S. Vietnamese Community
Addressing HPV Vaccine Hesitancy by Co-Designing a Digital Health Intervention
PREVENT HPV -Related Cancers Trial
PREVENT Pilot HPV - Related Cancers Trial
Empowering Vietnamese Americans
A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared to the Gardasil® Quadrivalent Vaccine Among Girls and Boys Aged 9 to 14 Years and in Girls/Women Aged 15 to 20 Years in Zambia
Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI
Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children
Study for Prevention of Cervical Cancer in Spain
Integrated HPV Vaccination and Adolescent Health in Ivory Coast
PREVENT HPV-Related Cancers - BootCamp Translation
Impact of Catch-up HPV Vaccination
Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents
Evaluation of the Implementation and Effectiveness of IPP-HPV
Impact of HPV Vaccination to Catch up in the Emergence of Lesions of the Cervix
Health Belief Model-based Education and Motivational Interview Regarding the HPV Vaccination Decision
Increasing HPV Vaccination Rates Via Educational Interventions in Schools Located Within Cedars-Sinai Catchment Areas